Neposredni dostop do osnovnega menija (pritisnite Enter)
Dostop do vsebine strani (pritisnite "Vstopi")
Neposredni dostop do seznama drugih spletnih mest (pritisnite Enter)

Odbor za okolje, javno zdravje in varnost hrane

ENVISeja odbora -14:38 / 16:41 - 03-12-2019
 
 
Če želite povezavo do posnetka prejeti po elektronski pošti, vpišite svoj elektronski naslov v okvirček spodaj.
 
 
(Preberite izjavo)
 
 
 
 
Tema
This event is also available on our multidevice player.
Dnevni red
  • Mon, 2 Dec 2019 15:00 - 17:00
    • 1.0 Adoption of agenda
    • 2.0 Chair’s announcements
    • 3.0 Chair’s announcements concerning coordinators’ recommendations of 6 November and of 25 November 2019
    • 4.0 * Establishment of a framework to facilitate sustainable investment (ECON-ENVI (CJ36)) * Quality of water intended for human consumption (recast) * Minimum requirements for water reuse(ENVI/9/01588) Report back on ongoing interinstitutional negotiations
    • 5.0 Exchange of views with {XMLIT_NAME} Bjørn Hansen, Executive Director of ECHA
    • 6.0 (ENVI/9/01877) Objection pursuant to Rule 111(3): Delegated act on classification, labelling and packaging of substances and mixtures - titanium dioxide
    • 7.0 (ENVI/9/01817) Objection pursuant to Rule 112: Imports of petfood from Saudi-Arabia
    • 8.0 (ENVI/9/01714) Objection pursuant to Rule 112: Imposing special conditions governing the import of feed and food originating in or consigned from Japan following the accident at the Fukushima nuclear power station (D063901)
    • 9.0 (ENVI/9/01882) Objection pursuant to Rule 112: the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (D064213-01)
  • Mon, 2 Dec 2019 17:00 - 18:30
    • In camera
    • 10.0 Coordinators’ meeting
  • Tue, 3 Dec 2019 09:30 - 10:30
    • 11.0 Exchange of views with {XMLIT_NAME} Dr Werner Hoyer, President of the European Investment Bank, on the transformation of part of the bank into a Climate Bank
  • Tue, 3 Dec 2019 10:30 - 12:30
    • *** Electronic vote ***
    • 12.0 (ENVI/9/01877) Objection pursuant to Rule 111(3): Delegated act on classification, labelling and packaging of substances and mixtures - titanium dioxide
    • 13.0 (ENVI/9/01817) Objection pursuant to Rule 112: Imports of petfood from Saudi-Arabia
    • 14.0 (ENVI/9/01714) Objection pursuant to Rule 112: Imposing special conditions governing the import of feed and food originating in or consigned from Japan following the accident at the Fukushima nuclear power station (D063901)
    • 15.0 (ENVI/9/01882) Objection pursuant to Rule 112: the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (D064213-01)
    • 16.0 (ENVI/9/01240) Strategic approach to pharmaceuticals in the environment
    • 17.0 (ENVI/9/01248) COP15 to the Convention on Biological Diversity (CBD) - Kunming (2020)
    • 18.0 (ENVI/9/01217) EU Pollinators Initiative
    • 19.0 (ENVI/9/01218) Enabling the digital transformation of health and care in the Digital Single Market; empowering citizens and building a healthier society
    • Corrigenda (Rule 241)
    • 20.0 (ENVI/9/01996) CORRIGENDUM to Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (OJ L 117, 5.5.2017, p. 176) (position of the European Parliament adopted at second reading on 5 April 2017 with a view to the adoption of the above regulation P8_TA(2017)0108) - (10729/4/2016 – C8-0105/2017 – 2012/0267(COD))
    • 21.0 (ENVI/9/01997) CORRIGENDUM to Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (OJ L 117, 5.5.2017, p. 1) (position of the European Parliament adopted at second reading on 5 April 2017 with a view to the adoption of the above regulation P8_TA(2017)0107) - (10728/4/2016 – C8-0104/2017 – 2012/0266(COD))
    • *** End of electronic vote ***
    • 22.0 (ENVI/9/01240) Strategic approach to pharmaceuticals in the environment
  • Tue, 3 Dec 2019 14:30 - 18:30
    • Joint debate
    • 23.0 (ENVI/9/01030) 2018 discharge: General budget of the EU - European Commission
    • 24.0 (ENVI/9/00860) 2018 discharge: European Environment Agency (EEA)
    • 25.0 (ENVI/9/00854) 2018 discharge: European Medicines Agency (EMA)
    • 26.0 (ENVI/9/00827) 2018 discharge: European Chemicals Agency (ECHA)
    • 27.0 (ENVI/9/00842) 2018 discharge: European Centre for Disease Prevention and Control (ECDC)
    • 28.0 (ENVI/9/00844) 2018 discharge: European Food Safety Authority (EFSA)
    • * * *
    • 29.0 (ENVI/9/01219) European Year of Greener Cities 2021
    • 30.0 (ENVI/9/00448) Amending Decision No 1313/2013/EU of the European Parliament and of the Council on a Union Civil Protection Mechanism
    • 31.0 Exchange of views with {XMLIT_NAME} the Commission on the evaluation of the Union legislation on blood, tissues and cells
    • 32.0 Any other business
    • 33.0 Next meetings (ENVI(2019)1216_1) Mon, 16 Dec 2019
    • Next meetings (ENVI(2020)0109_1) Thu, 9 Jan 2020